不眠症に対するレンボレキサントの長期研究（SUNRISE 2）

基本情報

NCT ID: NCT02952820
ステータス: 完了
試験のフェーズ: 第3相
試験タイプ: 介入
目標被験者数: 971
治験依頼者名: Eisai Inc.

概要

The key objectives of this study are to determine, using sleep diaries, whether lemborexant at the doses 5 milligrams (mg) and 10 mg is superior to placebo on subjective sleep onset, subjective sleep efficiency, and subjective sleep maintenance in participants with insomnia disorder.

対象疾患

Insomnia Disorder

介入

lemborexant(DRUG)

Placebo(DRUG)

依頼者（Sponsor）

エーザイ株式会社(INDUSTRY)

実施施設 (21)

Eisai Trail Site 1

Musashino, Tokyo, Japan

Eisai Trail Site 3

Sapporo, Hokkaido, Japan

Eisai Trail Site 2

Shinjuku, Tokyo, Japan

Eisai Trail Site 1

Toshima City, Tokyo, Japan

Eisai Trail Site 4

Sapporo, Hokkaido, Japan

Eisai Trail Site 1

Tokorozawa, Saitama, Japan

Eisai Trail Site 1

Arakawa City, Tokyo, Japan

Eisai Trail Site 2

Shinagawa, Tokyo, Japan

Eisai Trail Site 2

Sapporo, Hokkaido, Japan

Eisai Trail Site 1

Sagamihara, Kanagawa, Japan

Eisai Trail Site 1

Shinjuku, Tokyo, Japan

Eisai Trail Site 2

Ōta-ku, Tokyo, Japan

Eisai Trail Site 1

Shibuya City, Tokyo, Japan

Eisai Trail Site 3

Ōta-ku, Tokyo, Japan

Eisai Trail Site 1

Minato, Tokyo, Japan

Eisai Trail Site 1

Shinagawa, Tokyo, Japan

Eisai Trail Site 1

Katsushika-ku, Tokyo, Japan

Eisai Trail Site 1

Ōta-ku, Tokyo, Japan

Eisai Trail Site 1

Sapporo, Hokkaido, Japan

Eisai Trail Site 2

Minato, Tokyo, Japan

Eisai Trail Site 1

Maebashi, Gunma, Japan